Dogwood Therapeutics, Inc.
DWTX
$1.94
-$0.10-4.90%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -202.82% | 54.36% | 51.08% | -590.34% | -262.68% |
| Total Depreciation and Amortization | -3.47% | -1.18% | 36.07% | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -100.00% | -- | -- |
| Total Other Non-Cash Items | 11,975.17% | -92.28% | -97.77% | 12,723.75% | -59.70% |
| Change in Net Operating Assets | 321.89% | 53.58% | 102.05% | -71.66% | -432.21% |
| Cash from Operations | 10.31% | 2.04% | 40.68% | -259.61% | -396.01% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -100.00% | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 160.67% | -- | -- | -- |
| Repurchase of Common Stock | 100.00% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 100.00% | 53.16% | -99.79% | 100.00% | -108.27% |
| Foreign Exchange rate Adjustments | -166.34% | -183.33% | 101.87% | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 12.53% | 149.08% | -128.12% | -234.16% | -745.58% |